Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inhibrx Biosciences (INBX) Non-Current Debt (2023 - 2025)

Historic Non-Current Debt for Inhibrx Biosciences (INBX) over the last 2 years, with Q3 2025 value amounting to $99.9 million.

  • Inhibrx Biosciences' Non-Current Debt changed N/A to $99.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $99.9 million, marking a year-over-year change of. This contributed to the annual value of $207.0 million for FY2023, which is N/A changed from last year.
  • Inhibrx Biosciences' Non-Current Debt amounted to $99.9 million in Q3 2025.
  • Inhibrx Biosciences' Non-Current Debt's 5-year high stood at $207.0 million during Q4 2023, with a 5-year trough of $98.7 million in Q1 2025.